Literature DB >> 23717736

Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Christopher M Moore1, David H Van Thiel.   

Abstract

Ascites is a pathologic accumulation of peritoneal fluidcommonly observed in decompensated cirrhotic states.Its causes are multi-factorial, but principally involve significant volume and hormonal dysregulation in the setting of portal hypertension. The diagnosis of ascites is considered in cirrhotic patients given a constellation of clinical and laboratory findings, and ultimately confirmed, with insight into etiology, by imaging and paracentesis procedures. Treatment for ascites is multi-modal including dietary sodium restriction, pharmacologic therapies, diagnostic and therapeutic paracentesis, and in certain cases transjugular intra-hepatic portosystemic shunt. Ascites is associated with numerous complications including spontaneous bacterial peritonitis, hepato-hydrothorax and hepatorenal syndrome. Given the complex nature of ascites and associatedcomplications, it is not surprising that it heralds increased morbidity and mortality in cirrhotic patients and increased cost-utilization upon the health-care system. This review will detail the pathophysiology of cirrhotic ascites, common complications derived from it, and pertinent treatment modalities.

Entities:  

Keywords:  Ascites; Cirrhosis; Hepato-hydrothorax; Hepatorenal syndrome; Spontaneous bacterial peritonitis

Year:  2013        PMID: 23717736      PMCID: PMC3664283          DOI: 10.4254/wjh.v5.i5.251

Source DB:  PubMed          Journal:  World J Hepatol


  128 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 2.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

3.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

4.  Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.

Authors:  Joan Clària; Jeffrey D Kent; Marta López-Parra; Ginés Escolar; Luís Ruiz-Del-Arbol; Pere Ginès; Wladimiro Jiménez; Boris Vucelic; Vicente Arroyo
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

5.  Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial.

Authors:  Alexander L Gerbes; Veit Gülberg; Pere Ginès; Guy Decaux; Peter Gross; Hassan Gandjini; Jacques Djian
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

6.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.

Authors:  P Ginés; V Arroyo; E Quintero; R Planas; F Bory; J Cabrera; A Rimola; J Viver; J Camps; W Jiménez
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

8.  Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.

Authors:  Christophe Bureau; Juan Carlos Garcia Pagan; Gilles Pomier Layrargues; Sophie Metivier; Pablo Bellot; Pierre Perreault; Philippe Otal; Juan-G Abraldes; Jean Marie Peron; Hervé Rousseau; Jaume Bosch; Jean Pierre Vinel
Journal:  Liver Int       Date:  2007-08       Impact factor: 5.828

9.  Comparison of loop diuretics in patients with chronic renal insufficiency.

Authors:  J R Voelker; D Cartwright-Brown; S Anderson; J Leinfelder; D A Sica; J P Kokko; D C Brater
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.

Authors:  Rubén Terg; Eduardo Fassio; Mónica Guevara; Mariano Cartier; Cristina Longo; Romina Lucero; Cristina Landeira; Gustavo Romero; Nora Dominguez; Alberto Muñoz; Diana Levi; Carlos Miguez; Raquel Abecasis
Journal:  J Hepatol       Date:  2008-02-14       Impact factor: 25.083

View more
  27 in total

Review 1.  Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.

Authors:  Brian Erly; William D Carey; Baljendra Kapoor; J Mark McKinney; Mathew Tam; Weiping Wang
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study.

Authors:  Maria Stepanova; Fatema Nader; Christophe Bureau; Danielle Adebayo; Laure Elkrief; Dominique Valla; Markus Peck-Radosavljevic; Anne McCune; Victor Vargas; Macarena Simon-Talero; Juan Cordoba; Paolo Angeli; Silvia Rossi; Stewart MacDonald; Jeroen Capel; Rajiv Jalan; Zobair M Younossi
Journal:  Qual Life Res       Date:  2018-02-19       Impact factor: 4.147

Review 3.  Acute kidney injury in the ICU: from injury to recovery: reports from the 5th Paris International Conference.

Authors:  Rinaldo Bellomo; Claudio Ronco; Ravindra L Mehta; Pierre Asfar; Julie Boisramé-Helms; Michael Darmon; Jean-Luc Diehl; Jacques Duranteau; Eric A J Hoste; Joannes-Boyau Olivier; Matthieu Legrand; Nicolas Lerolle; Manu L N G Malbrain; Johan Mårtensson; Heleen M Oudemans-van Straaten; Jean-Jacques Parienti; Didier Payen; Sophie Perinel; Esther Peters; Peter Pickkers; Eric Rondeau; Miet Schetz; Christophe Vinsonneau; Julia Wendon; Ling Zhang; Pierre-François Laterre
Journal:  Ann Intensive Care       Date:  2017-05-04       Impact factor: 6.925

Review 4.  Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis.

Authors:  Antonio Facciorusso; Annabianca Amoruso; Viviana Neve; Matteo Antonino; Valentina Del Prete; Michele Barone
Journal:  World J Hepatol       Date:  2014-11-27

Review 5.  Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.

Authors:  Sith Siramolpiwat
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.

Authors:  Xin Zhang; Shu-Zhen Wang; Jun-Fu Zheng; Wen-Min Zhao; Peng Li; Chun-Lei Fan; Bing Li; Pei-Ling Dong; Lei Li; Hui-Guo Ding
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Treatment for ascites in adults with decompensated liver cirrhosis: a network meta-analysis.

Authors:  Amine Benmassaoud; Suzanne C Freeman; Davide Roccarina; Maria Corina Plaz Torres; Alex J Sutton; Nicola J Cooper; Laura Iogna Prat; Maxine Cowlin; Elisabeth Jane Milne; Neil Hawkins; Brian R Davidson; Chavdar S Pavlov; Douglas Thorburn; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-16

Review 8.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  Imaging and clinical predictors of spontaneous bacterial peritonitis diagnosed by ultrasound-guided paracentesis.

Authors:  Andrew Sideris; Pooja Patel; Hearns W Charles; James Park; David Feldman; Amy R Deipolyi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

10.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.